Nuo Therapeutics, Inc.
OTC: AURX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David E. Jorden
- Employees
- 9
- Headquarters
- Houston, United States
- IPO year
- 2017
- Market cap
- $43.8M
- Website
- https://www.nuot.com
Loading AURX…
Loading profile data…Frequently asked questions about AURX
What does Nuo Therapeutics, Inc. (AURX) do?
Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings...
Where does AURX trade?
Nuo Therapeutics, Inc. (AURX) trades on the Other OTC.
What sector is AURX in?
Nuo Therapeutics, Inc. (AURX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Nuo Therapeutics, Inc.?
David E. Jorden is the chief executive officer of Nuo Therapeutics, Inc. (AURX).
Where is Nuo Therapeutics, Inc. headquartered?
Nuo Therapeutics, Inc. is headquartered in United States.
Does AURX pay a dividend?
Nuo Therapeutics, Inc. (AURX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AURX go public?
Nuo Therapeutics, Inc. (AURX) completed its initial public offering in 2017.